PROPECIA, an FDA-approved pill, is different. PROPECIA is the only once-a-day pill approved by the FDA for the treatment of certain types of male pattern hair loss (MPHL) in men. PROPECIA reduces DHT, a key cause of hair loss. Clinical studies of PROPECIA demonstrated visible results.
PROPECIA significantly reduces DHT, a key cause of hair loss, by inhibiting the formation of DHT in your scalp. Reducing DHT appears to inhibit the further shrinking of affected hair follicles.
Hair loss due to MPHL is progressive, so the earlier you start taking PROPECIA, the better. The 5-year clinical study demonstrated the benefit of treating hair loss earlier with PROPECIA.a
View how men saw improvement over 2 and 5 years on PROPECIA.
PROPECIA is for the treatment of male pattern hair loss in MEN ONLY and should NOT be used by women or children. You should not use PROPECIA if you are allergic to finasteride or any of the ingredients in PROPECIA.
More than 1 million men in the United States have used PROPECIA since the drug’s introduction in 1998. Meet 6 of them and learn their stories.
Straight answers about MPHL and PROPECIA.
PROPECIA was developed to treat mild to moderate male pattern hair loss on the vertex (top of head) and anterior mid-scalp area (middle front of head) in MEN ONLY. There is not sufficient evidence that PROPECIA works for receding hairlines at the temples.
Women who are or may potentially be pregnant must not use PROPECIA and should not handle crushed or broken PROPECIA tablets because the active ingredient may cause abnormalities of a male baby’s sex organs. If a woman who is pregnant comes into contact with the active ingredient in PROPECIA, a doctor should be consulted.
PROPECIA tablets are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets are not broken or crushed.
Women who are or may potentially be pregnant must not use PROPECIA and should not handle crushed or broken PROPECIA tablets because the active ingredient may cause abnormalities of a male baby’s sex organs. If a woman who is pregnant comes into contact with the active ingredient in PROPECIA, a doctor should be consulted.
PROPECIA tablets are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets are not broken or crushed.
Take 1 tablet by mouth each day, with or without food.
PROPECIA will not work faster or better if you take it more than once a day.
If you forget to take PROPECIA, do not take an extra tablet. Just take the next tablet as usual.
PROPECIA will not work faster or better if you take it more than once a day.
If you forget to take PROPECIA, do not take an extra tablet. Just take the next tablet as usual.
A 5-year clinical study demonstrated the effectiveness of PROPECIA.
- 9 of 10 men who took PROPECIA had visible results—either regrowth of hair (48% [134 of 279]) or no further hair loss (42% [117 of 279])—vs 25% [4 of 16] who took a placebo (sugar pill), according to an assessment of photographs by an independent panel of dermatologists.
- 2 of 3 men who took PROPECIA regrew hair, as measured by hair count. All of the men in the study who were not taking PROPECIA lost hair.
- A majority of men who took PROPECIA were rated as improved by doctors—77% (210 of 271) vs 15% (2 of 13) of men who took a placebo.
- A majority of men who took PROPECIA reported that their bald spot got smaller, their hair loss slowed down, and the appearance of their hair improved.
Know the facts. PROPECIA is available by prescription only, so the best thing to do is talk with your doctor.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
PROPECIA and Helping make hair loss history are registered trademarks of Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc.
20951234(2)-04/10-PRP
You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
PROPECIA and Helping make hair loss history are registered trademarks of Merck Sharp & Dohme Corp. a subsidiary of Merck & Co., Inc.
20951234(2)-04/10-PRP
